Autoimmunity and ALS

Neurology

Volumn 47, Issue 4 SUPPL., 1996, Pages

  Smith, R G ^a   Siklos, L ^c   Alexianu, M E ^a   Engelhardt, J I ^b   Mosier, D R ^a   Colom, L ^a   Mohamed, A Habib ^a   Appel, S H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM CHANNEL; CALCIUM ION; IMMUNOGLOBULIN;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOIMMUNITY; CALCIUM CELL LEVEL; CELL DEATH; CELL SWELLING; CHANNEL GATING; ETIOLOGY; GOLGI COMPLEX; HUMAN; MOTONEURON; NEUROMUSCULAR SYNAPSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0029851513     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.4_suppl_2.40s     Document Type: Review

References (65)

1. Rowland LP. Motor neuron diseases and amyotrophic lateral sclerosis. Trends Neurosci 1985;7:110-112.
2. Appel SH, Stockton-Appel V, Stewart SS. Amyotrophic lateral sclerosis: associated clinical disorders and immunologic evaluations. Arch Neurol 1986;43:234-238.
3. Norris F, Shepherd R, Denys E, et al. Onset, natural history, and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48-55.
4. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Brain 1995; 118:707-719.
5. Kurtzke JF, Kurland LT. The epidemiology of neurologic disease. In: Joynt RJ, ed. Clinical Neurology, Vol. 4. Philadelphia: J.B. Lippincott, 1983:1-43.
6. Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol 1991;48:589-593.
7. Ringel SP, Murphy JR, Alderson MK, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43:1316-1322.
8. Siddique T, Figlewicz D, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21, and evidence of genetic locus heterogeneity. N Engl J Med 1991;324:1381-1384.
9. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
10. Okamato K, Hirai S, Amari M, et al. Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathol 1993;85:458-462.
11. Mizutani T, Sakamaki S, Tsuchiya N, et al. Amyotrophic lateral sclerosis with opthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol 1992;84:372-377.
12. Sasaki S, Maruyama S. A fine structural study of Onuf's nucleus in sporadic amyotrophic lateral sclerosis. J Neurol Sci 1993;119:28-37.
13. Gonatas NK, Stieber A, Mourelatos Z, et al. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol 1991;140:731-737.
14. Hirano A. Aspects of ultrastructure of amyotrophic lateral sclerosis. In: Rowland LP, ed. Human motor neuron disease. New York: Raven Press, 1982:75-88.
15. Sasaki S, Maruyama S. Ultrastructural study of skein-like inclusions in anterior-horn neurons of patients with motor neuron disease. Neurosci Lett 1992;147:121-124.
16. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 1968;18:841-851.
17. Hayashi H, Kato S. Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state. J Neurol Sci 1989;93:19-35.
18. Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 1993;50:30-36.
19. Panzera MA, Oksenberg, Begovich A, et al. Restricted T-cell receptor usage in spinal cord and brain of patients with amyotrophic lateral sclerosis. J Neuroimmunol 1991;28(suppl 1):79.
20. Latov N, Hays AP, Donofrio PD, et al. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lactotetraose associated with human motor neuron disease. Neurology 1988;38:763-768.
21. Younger DS, Rowland LP, Latov N, et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990;40:595-599.
22. Meininger V, Duarte F, Binet S, et al. Serum monoclonal immunoglobulin in amyotrophic lateral sclerosis: a quantitative analysis using a new Western blot technique. Neurology 1990;40(suppl 1):183.
23. Smith RG, Engelhardt JI, Tajti J, et al. Experimental immune-mediated motor neuron diseases: models for human ALS. Brain Res Bull 1993;30:373-380.
24. 3 in the spinal cord and motor cortex of ALS patients. J Neuroimmunol 1984;6:51-57.
25. Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 1990;47:210-211.
26. Engelhardt JI, Appel SH, Killian JM. Experimental autoimmune motoneuron disease. Ann Neurol 1989;26:368-376.
27. Engelhardt JI, Appel SH, Killian JM. Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease. J Neuroimmunol 1990;27:21-31.
28. Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 1993;50:30-36.
29. Appel SH, Engelhardt JI, Garcia J, et al. Immunoglobulins from animal models of motor neuron disease and human ALS passively transfer physiological abnormalities of the neuromuscular junction. Proc Natl Acad Sci USA 1991;88:647-651.
30. Uchitel OD, Scornik F, Protti DA, et al. Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins. Neurology 1992;42:2175-2180.
31. Robitaille R, Adler EM, Charlton MP. Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses. Neuron 1990;5:773-779.
32. Uchitel OD, Protti DA, Sanchez V, et al. P-type voltage-dependent calcium influx and transmitter release in mammalian synapses. Proc Natl Acad Sci USA 1992;89:3330-3333.
33. Engelhardt JI, Siklos L, Komuves L, et al. Antibodies to calcium channels from ALS patients passively transferred into mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 1995;20:185-199.
34. Siklos L, Engelhardt J, Harati Y, et al. Ultrastructural evidence of altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol (in press).
35. Delbono O, García J, Appel SH, et al. Calcium current and charge movement of mammalian muscle: action of amyotrophic lateral sclerosis immunoglobulins. J Physiol 1991;444: 723-742.
36. Delboho O, Garcia J, Appel SH, et al. IgG from amyotrophic lateral sclerosis affects tubular calcium channels of skeletal muscle. Am J Physiol 1991;260:C1347-C1351.
37. ab fragments from amyotrophic lateral sclerosis IgG affect calcium channels of skeletal muscle. Am J Physiol 1993;264:C537-C543.
38. 2+ channels. J Physiol 1993;461:103-118.
39. Mosier DR, Delbono O, Olcese R, et al. Amyotrophic lateral sclerosis IgG enhances brain calcium currents expressed in Xenopus oocytes. Soc Neurosci Abstr 1994;20:620.
40. Llinas R, Sugimori M, Cherksey BD, et al. IgG from amyotrophic lateral sclerosis patients increase current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayers. Proc Natl Acad Sci USA 1993;90:11743-11747.
41. O'Shaughnessy MP, Viglioni H, Kim YI. Effect of ALS plasma on calcium currents in bovine adrenal cells. Soc Neurosci Abstr 1993;19:234.
42. Smith RG, Hamilton S, Hoffman F, et al. Serum antibodies to skeletal muscle-derived L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 1992;327: 1721-1728.
43. Lennon VA, Kryzer TJ, Griessmann GE, et al. Calcium channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
44. 1 subunit. Ann Neurol 1994;35:164-171.
45. Smith RG, Kimura F, Harati Y, et al. Altered muscle calcium channel binding kinetics in autoimmune motoneuron diseases. Muscle Nerve 1995;18:620-627.
46. Crawford GD, Le W-D, Smith RG, et al. A novel N18TG2 x mesencephalon hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 1992;12:3392-3398.
47. Cashman NR, Durham HD, Blusztajn JK, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dynam 1992;194:209-221.
48. Salazar-Gruezo EF, Kim S, Kim H. Embryonic mouse spinal cord motor neuron hybrid cells. Neuroreport 1991;2:505-508.
49. Mosier DR, Baldelli P, Delbono O, et al. Immunoglobulins from patients with amyotrophic lateral sclerosis increase calcium currents in a hybrid motoneuron cell line. Ann Neurol 1995;37:102-109.
50. Colom LV, Alexianu ME, Smith RG, et al. Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line. Soc Neurosci Abstr 1994;20:1649.
51. Smith RG, Alexianu M, Crawford G, et al. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci USA 1994;91:3393-3397.
52. Dubinsky JM. Intracellular calcium levels during the period of delayed excitotoxicity. J Neurosci 1993;13:623-631.
53. Alexianu ME, Mohamed AH, Smith RG, et al. Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with ALS. J Neurochem 1994;63: 2365-2368.
54. 2+-dependent oxygen free radical production mediates ALS IgG-induced cytotoxicity in vitro. Neurology 1995;45:A221.
55. Ince P, Stout N, Shaw P, et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 1993;19:291-299.
56. Alexianu ME, Ho B-K, Mohamed AH, et al. The role of calcium binding proteins and selective vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1994;36:846-858.
57. Alexianu ME, Ho B-K, Mohamed AH, et al. Stable calbindin D-28K expression in a motoneuron cell line prevents the toxicity induced by ALS IgG. Neurology 1995;45:A381.
58. Legendre P, Rosenmund C, Westbrook GL. Inactivation of NMDA channels in cultured hippocampal neurons by intracellular calcium. J Neurosci 1993;13:674-684.
59. Valentino K, Newcomb R, Gadborg T, et al. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci USA 1993;90: 7894-7897.
60. Koh J-Y, Cotman CW. Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists. Brain Res 1992;587:233-240.
61. Graham LT Jr, Shank RP, Werman R, et al. Distribution of some synaptic transmitter suspects in cat spinal cord: glutamic acid, aspartic acid, gamma-aminobutyric acid, glycine, and glutamine. J Neurochem 1967;14:465-472.
62. Rothstein J, Bristol LA, Hosler B, et al. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 1994;91:4155-4159.
63. Lafon-Cazal M, Pietri S, Culcasi M, et al. NMDA-dependent superoxide production and neurotoxicity. Nature 364:535-537.
64. 2+-dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons. Biochem J 1992;283:41-50.
65. Roveri A, Coassin M, Maiorino M, et al. Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells. Arch Biochem Biophys 1992;297:265-270.